↓ Cooling
Business
🔮 fades
FDA approves Vera Therapeutics kidney disease treatment
The FDA has approved Vera Therapeutics' dual-target drug, Trutakna, for the treatment of primary IgA nephropathy.
1 trends tracked about this subject — the full history, oldest to newest below.
The FDA has approved Vera Therapeutics' dual-target drug, Trutakna, for the treatment of primary IgA nephropathy.